U.S. Wealth WatcherCelebrating Political Fortunes
Back to Bills and Votes
HR 3029 · 119th CongressIntroduced

Biosecurity standards for DNA screening

Tech & Telecom
Vote
—
Donor money
—
Money gap
—
Summary

What the bill does

This bill directs the National Institute of Standards and Technology to develop best practices and technical standards for screening synthetic DNA to prevent misuse. It creates a consortium of industry, universities, and nonprofits to update these standards. The bill authorizes $5 million per year from 2027 to 2031 for this work.

Why it matters

The stakes

The bill aims to improve biosecurity by ensuring that companies that make synthetic DNA screen orders to prevent the creation of dangerous biological agents. This affects public health and safety, as well as the biotechnology industry.

Major public companies this covers
  • Twist BioscienceTWST
  • Ginkgo BioworksDNA
  • Thermo Fisher ScientificTMO
The vote

How the chamber split

Vote totals will appear when a roll-call is available.

The debate

What each side says

Supporters
  • The bill helps prevent bioterrorism by setting standards for screening synthetic DNA orders.bill
  • It brings together experts from industry, universities, and nonprofits to create effective and up-to-date guidelines.bill
  • The funding supports research to make screening more accurate and reliable.bill
Critics
  • No recorded objections.

Each point links to its source. The views are attributed to those sources, not stated as ours.

Money lens

Tech & Telecom money, split by party

The money lens appears when a bill has a recorded vote and matching sector PAC data.

Contributions and votes are public records, shown side by side. Correlation is not causation, and this page does not assert one caused the other.